BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32472416)

  • 1. ASO Author Reflections: Challenges in the Management of Synchronous Prostate Cancer and Rectal Cancer: Towards Double Organ Preservation?
    Doussot A; Lakkis Z
    Ann Surg Oncol; 2020 Oct; 27(11):4294-4295. PubMed ID: 32472416
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of synchronous rectal and prostate cancer.
    Kavanagh DO; Quinlan DM; Armstrong JG; Hyland JM; O'Connell PR; Winter DC
    Int J Colorectal Dis; 2012 Nov; 27(11):1501-8. PubMed ID: 22451255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum.
    Nash GF; Turner KJ; Hickish T; Smith J; Chand M; Moran BJ
    Ann R Coll Surg Engl; 2012 Oct; 94(7):456-62. PubMed ID: 23031761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
    Colonias A; Farinash L; Miller L; Jones S; Medich DS; Greenberg L; Miller R; Parda DS
    Nat Clin Pract Oncol; 2005 May; 2(5):271-4; quiz 1 p following 274. PubMed ID: 16264963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous malignant tumors in patients with head and neck cancer.
    Brownson RJ; Sessions DG; Porubsky ES; Ogura JH
    Arch Otolaryngol; 1973 Apr; 97(4):347-9. PubMed ID: 4699545
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST.
    Yaman E; Coskun U; Benekli M; Sozen S; Yamac D; Buyukberber S; Ozturk B; Kaya AO; Yildiz R; Tezel E
    Onkologie; 2008 Dec; 31(12):697-9. PubMed ID: 19060509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation in rectal cancer: towards the norm rather than the exception.
    Roxburgh CS
    Br J Surg; 2021 Jul; 108(7):745-747. PubMed ID: 34195801
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Inequities in Rectal Cancer Treatment and Survival.
    Hamilton KS; Aibuedefe B; Yong V; Kling SM; Zhao H; Poggio JL
    Ann Surg Oncol; 2022 Aug; 29(8):5063-5064. PubMed ID: 35312899
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Immunotherapy in Rectal Cancer Illusion or Nirvana.
    Wilson K; Heriot A
    Ann Surg Oncol; 2021 Nov; 28(12):7474-7475. PubMed ID: 34115252
    [No Abstract]   [Full Text] [Related]  

  • 10. The curative management of synchronous rectal and prostate cancer.
    Lavan NA; Kavanagh DO; Martin J; Small C; Joyce MR; Faul CM; Kelly PJ; O'Riordain M; Gillham CM; Armstrong JG; Salib O; McNamara DA; McVey G; O'Neill BD
    Br J Radiol; 2016; 89(1057):20150292. PubMed ID: 26539631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation.
    Hupkens BJP; Maas M
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):854-855. PubMed ID: 30421061
    [No Abstract]   [Full Text] [Related]  

  • 12. Putting down the scalpel in rectal cancer management - a historical perspective.
    Perez RO; Habr-Gama A
    Colorectal Dis; 2018 May; 20 Suppl 1():12-15. PubMed ID: 29878677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in Rectal Cancer Treatment and Management.
    Sun W; Al-Rajabi R; Perez RO; Abbasi S; Ash R; Habr-Gama A
    Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32239978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ preservation in rectal cancer: have all questions been answered?
    Marijnen CA
    Lancet Oncol; 2015 Jan; 16(1):e13-22. PubMed ID: 25638548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
    Mariani A; Goere D
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):818. PubMed ID: 31667730
    [No Abstract]   [Full Text] [Related]  

  • 17. Synchronous primary cancers: Renal cell carcinoma and rectal cancer.
    Babu MCS; Asati V; Babu KG; Suma MN; Rajeev LK; Lokesh KN
    J Cancer Res Ther; 2019; 15(1):250-251. PubMed ID: 30880786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: The Evolving Field of Oncoplastic Breast Conservation for the Management of Breast Cancer.
    Stein MJ; Arnaout A; Zhang J
    Ann Surg Oncol; 2020 Oct; 27(11):4513-4514. PubMed ID: 32458329
    [No Abstract]   [Full Text] [Related]  

  • 20. Leiomyosarcoma of the rectum and prostate.
    Stallwood G; Davidson JW
    Can J Surg; 1977 Sep; 20(5):446-9. PubMed ID: 890619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.